FDX1 and nonpapillary renal cell carcinoma: Together, all these findings highlight that resistance to cuproptosis under the miR-21-5p/FDX1 axis, as well as its educated tumor microenvironment is a potential mechanism driving ccRCC progression, and recovery of cuproptosis may be an alternative strategy to overcome this type of disease.